Latest filing published 06 Sept 2007 for Biocryst Pharmaceuticals INC, €53k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -37.0%Entry US$12.74 · Close at T+365 US$8.02
- -43.4%Entry US$15.96 · Close at T+365 US$9.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
J. Claude Bennett: trading record in brief
J. Claude Bennett appears in our data through filings on Biocryst Pharmaceuticals Inc shares, published by SEC (Form 4). Over a trading history stretching from 13 February 2006 to 4 September 2007, the count stands at 34 filings.
The open-market side counts 2 purchases for €212k alongside 21 sales for €852k. Taken together, the sales exceed the purchases by €640k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 11 option exercises. Since January 2007: no purchases and 1 sale on the market.
The record was last updated on 6 September 2007 with an option exercise (€53k) in Biocryst Pharmaceuticals Inc. The last insider purchase was made public on 11 May 2006, 7,487 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to J. Claude Bennett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,563 shares@ US$6.25Common StockSEC:0000882796-07-000060:0
- 8,437 shares@ US$6.50Common StockSEC:0000882796-07-000060:1
- 20,000 shares@ US$12.00Common StockSEC:0000882796-07-000060:2
- 1,000 shares@ US$1.18Common StockSEC:0000882796-07-000010:0
- 4,622 shares@ US$6.09Common StockSEC:0000882796-07-000010:1
- 10,549 shares@ US$6.25Common StockSEC:0000882796-07-000010:2
- 6,563 shares@ US$6.50Common StockSEC:0000882796-06-000021:0Canonical exit: 8 Aug 2006 (T+90)
- 35,000 shares@ US$6.50Common StockSEC:0000882796-06-000019:0Canonical exit: 1 Aug 2006 (T+90)
- 18,508 shares@ US$15.10Common StockSEC:0000882796-06-000019:2
- 535 shares@ US$15.14Common StockSEC:0000882796-06-000019:3
- 2,200 shares@ US$15.15Common StockSEC:0000882796-06-000019:4
- 4,811 shares@ US$15.25Common StockSEC:0000882796-06-000019:5
- 89 shares@ US$15.26Common StockSEC:0000882796-06-000019:6
- 100 shares@ US$15.07Common StockSEC:0000882796-06-000019:1
- 10,000 shares@ US$16.38Common StockSEC:0000882796-06-000016:0
- 684 shares@ US$16.38Common StockSEC:0000882796-06-000016:1
- 912 shares@ US$18.00Common StockSEC:0000882796-06-000016:2
- 3,240 shares@ US$18.01Common StockSEC:0000882796-06-000016:3
- 1,900 shares@ US$18.02Common StockSEC:0000882796-06-000016:4
- 1,912 shares@ US$18.04Common StockSEC:0000882796-06-000016:5
- 2,036 shares@ US$18.05Common StockSEC:0000882796-06-000016:6
- 10,000 shares@ US$16.38Common StockSEC:0000882796-06-000010:0
- 1,550 shares@ US$16.38Common StockSEC:0000882796-06-000010:1
- 1,400 shares@ US$20.93Common StockSEC:0000882796-06-000010:2
- 87 shares@ US$20.97Common StockSEC:0000882796-06-000010:3
25 of 34 declarations
